Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen-Yi Yang

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Diabetes Research and Clinical Practice|March 12, 2025
Visit-to-visit lipid variability and adverse kidney events in real-world type 2 diabetes patientsHsuan-Yu Su, Yi-Hsin Chang, Chen-Yi Yang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2016
Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 YearsHuang-Tz Ou, Chen-Yi Yang, Jung-Der Wang, et al.
Cardiovascular Diabetology|October 18, 2024
Non-alcoholic fatty liver disease risk with GLP-1 receptor agonists and SGLT-2 inhibitors in type 2 diabetes: a nationwide nested case-control studyKai-Cheng Chang, Fan-Chi Kuo, Chen-Yi Yang, et al.
Journal of Internal Medicine|November 23, 2023
Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation frameworkChun-Ting Yang, Wen-Yu Yao, Chen-Yi Yang, et al.
Cardiovascular Diabetology|October 8, 2021
Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center studyFang-Ju Lin, Chi-Chuan Wang, Chien-Ning Hsu, et al.
JAMA Network Open|October 30, 2024
Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 DiabetesHsuan-Yu Su, Chen-Yi Yang, Yu-Hsuan Lee, et al.
Medicine|September 17, 2025
Effect of oral preemptive analgesia on pain management after total knee arthroplasty: A systematic review and meta-analysis of randomized control trialsJian-Chao Hu, Fan-Jie Xiong, Wei Zhao, et al.
Neurospine|April 5, 2021
The Underdiagnosed, Understudied Complexity of Pseudoangina: Should Clinicians Take a Neurosurgical Approach in Diagnosing Unexplained Visceral Pain?Nolan J Brown, Shane Shahrestani, Elliot H Choi, et al.
Clinical Pharmacology and Therapeutics|September 26, 2020
Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes PatientsChen-Yi Yang, Wei-Ann Lin, Pei-Fang Su, et al.
JAMA Network Open|January 12, 2023
Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector PerspectiveHsuan-Yu Su, Chen-Yi Yang, Huang-Tz Ou, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Diabetes Research and Clinical Practice|March 12, 2025
Visit-to-visit lipid variability and adverse kidney events in real-world type 2 diabetes patientsHsuan-Yu Su, Yi-Hsin Chang, Chen-Yi Yang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2016
Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 YearsHuang-Tz Ou, Chen-Yi Yang, Jung-Der Wang, et al.
Cardiovascular Diabetology|October 18, 2024
Non-alcoholic fatty liver disease risk with GLP-1 receptor agonists and SGLT-2 inhibitors in type 2 diabetes: a nationwide nested case-control studyKai-Cheng Chang, Fan-Chi Kuo, Chen-Yi Yang, et al.
Journal of Internal Medicine|November 23, 2023
Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation frameworkChun-Ting Yang, Wen-Yu Yao, Chen-Yi Yang, et al.
Cardiovascular Diabetology|October 8, 2021
Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center studyFang-Ju Lin, Chi-Chuan Wang, Chien-Ning Hsu, et al.
JAMA Network Open|October 30, 2024
Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 DiabetesHsuan-Yu Su, Chen-Yi Yang, Yu-Hsuan Lee, et al.
Medicine|September 17, 2025
Effect of oral preemptive analgesia on pain management after total knee arthroplasty: A systematic review and meta-analysis of randomized control trialsJian-Chao Hu, Fan-Jie Xiong, Wei Zhao, et al.
Neurospine|April 5, 2021
The Underdiagnosed, Understudied Complexity of Pseudoangina: Should Clinicians Take a Neurosurgical Approach in Diagnosing Unexplained Visceral Pain?Nolan J Brown, Shane Shahrestani, Elliot H Choi, et al.
Clinical Pharmacology and Therapeutics|September 26, 2020
Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes PatientsChen-Yi Yang, Wei-Ann Lin, Pei-Fang Su, et al.
JAMA Network Open|January 12, 2023
Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector PerspectiveHsuan-Yu Su, Chen-Yi Yang, Huang-Tz Ou, et al.
Pageof 5